Advertisement

Preconception Care

  • Brian W. Jack
  • Larry Culpepper

Abstract

Family physicians have practiced risk reduction in preparation for pregnancy for many years as part of such activities as premarital counseling, family planning, and genetic counseling. In recent years there is a growing realization that poor obstetric outcomes can be prevented by more comprehensively assessing and modifying medical, psychosocial, and behavioral risk before pregnancy. This concept, called preconception care, can help parents make decisions regarding the timing of conception and can improve their readiness for pregnancy.1

Keywords

Prenatal Care Family Physician Bacterial Vaginosis Spina Bifida Neural Tube Defect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    US Public Health Service Expert Panel on the Content of Prenatal Care. Caring for our future: the content of prenatal care. Washington, DC: US Department of Health and Human Services, 1989.Google Scholar
  2. 2.
    Jack B, Culpepper L. Preconception care: risk reduction and health promotion in preparation for pregnancy. JAMA 1990; 264:1147–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Jack B, Culpepper L. Preconception care. In: Merkatz IR, Thompson JE, Mullen PD, Goldenberg RL, editors. New perspectives on prenatal care. New York: Elsevier, 1990: 69–88.Google Scholar
  4. 4.
    Healthy people 2000: midcourse review and 1995 revisions. Washington, DC: US Department of Health and Human Services, Public Health Service.Google Scholar
  5. 5.
    Jack BW, Culpepper L. Preconception care. J Fam Pract 1991; 32:306–15.PubMedGoogle Scholar
  6. 6.
    Gjerdingen DK, Fontaine P. Preconception health care: a critical task for family physicians. J Am Board Fam Pract 1991; 4:237–50.PubMedGoogle Scholar
  7. 7.
    Jack B. Preconception care (or how all family physicians “do” OB). Am Fam Physician 1995;51:1807–8.PubMedGoogle Scholar
  8. 8.
    Miller CA. Wanting children. Am J Public Health 1992;82: 341–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Jack BW, Campanile C, McQuade W, Kogan MD. The negative pregnancy test: an opportunity for preconception care. Arch Fam Med 1995;4:340–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Adams MM, Bruce FC, Shulman HB, Kendrick JS, Brogan DJ. Pregnancy planning and preconception counseling. Obstet Gynecol 1993;82:955–9.PubMedGoogle Scholar
  11. 11.
    Davis SF, Byers RH, Lindegren ML, Caldwell MB, Karon JM, Gwinn M. Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA 1995;274:952–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Connor EM, Sperling RS, Gelbert R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173–80.PubMedCrossRefGoogle Scholar
  13. 13.
    Centers for Disease Control Immunization Practices Advisory Committee. Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR 1988;37:341–6.Google Scholar
  14. 14.
    Stevens CE, Toy PT, Tong MJ, et al. Perinatal hepatitis B virus transmission in the United States: prevention by passive-active immunization. JAMA 1985;253:1740–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Centers for Disease Control. Changing patterns of groups at high risk for hepatitis B in the United States. MMWR 1988; 37:429–32.Google Scholar
  16. 16.
    Margolis HS, Coleman PJ, Brown RE, et al. Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations. JAMA 1995; 274:1201–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Wilson CB, Remington JS. What can be done to prevent congenital toxoplasmosis? Am J Obstet Gynecol 1980;138: 357–63.PubMedGoogle Scholar
  18. 18.
    Krick JA, Remington JS. Toxoplasmosis in the adult—an overview. N Engl J Med 1978;298:550–3.PubMedCrossRefGoogle Scholar
  19. 19.
    Fuccillo DA, Madden DL, Tzan NR, et al. Difficulties associated with serological diagnosis of Toxoplasma gondii infections. Diagn Clin Imunol 1987;5:8–13.Google Scholar
  20. 20.
    Centers for Disease Control. Rubella and congenital rubella syndrome—United States, 1985–1988. MMWR 1989; 38:172–88.Google Scholar
  21. 21.
    Centers for Disease Control. Rubella vaccination during pregnancy—United States, 1971–1988. MMWR 1989;38: 289–93.Google Scholar
  22. 22.
    Paryani SG, Avrin AM. Intrauterine infections with varicella-zoster virus after maternal varicella. N Engl J Med 1986;34:1542.CrossRefGoogle Scholar
  23. 23.
    American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the use of live attenuated varicella vaccine. Pediatrics 1995;95:761–6.Google Scholar
  24. 24.
    Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low birthweight infant. N Engl J Med 1995;333:1737–42.PubMedCrossRefGoogle Scholar
  25. 25.
    Hauth JC, Goldenberg RL, Andrews WW, et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Culpepper L, Thompson JE. Work during pregnancy. In: Merkatz IR, Thompson JE, Mullen PD, Goldenberg R, editors. New perspectives on prenatal care. New York: Elsevier, 1990:211–34.Google Scholar
  27. 27.
    Teratology Society. Recommendations for isotretinoin use in women of childbearing potential. Teratology 1991;44:1–6.CrossRefGoogle Scholar
  28. 28.
    Barrett JM, Van Hooydonk JE, Boehm FH. Pregnancy-related rupture of arterial aneurysms. Obstet Gynecol Surv 1982;37: 557–66.PubMedCrossRefGoogle Scholar
  29. 29.
    Steel JM. Johnston FD. Prepregnancy management of the diabetic. In: Chamberlain G, Lumley J, editors. Prepregnancy care: a manual for practice. Chichester: Wiley, 1986: 165–82.Google Scholar
  30. 30.
    Kitzmiller JL, Gavin LA, Gin GD, et al. Preconception care of diabetes: glycemie control prevents congenital anomalies. JAMA 1991;2645:731–6.Google Scholar
  31. 31.
    Elixhauser A, Weschler JM, Kitzmiller JL. Cost-benefit analysis of preconception care for women with established diabetes mellitus. Diabetes Care 1993;16:1146–57.PubMedCrossRefGoogle Scholar
  32. 32.
    Taysi K. Preconceptional counseling. Obstet Gynecol Clin North Am 1988;15:167–78.PubMedGoogle Scholar
  33. 33.
    Delgado-Escueta AV, Janz D. Consensus guideline: preconception counseling, management, and care of the pregnant women with epilepsy Neurology 1992;42:149–60.Google Scholar
  34. 34.
    Momotani N, Noh J, Oyanagi H, Ishikawa N, Ito K. Antithyroid drug therapy of Graves’ disease during pregnancy: optimal regimen for fetal thyroid status. N Engl J Med 1986; 315:24–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Man EB, Brown JF, Surunaian SA. Maternal hypothyroxine-mia: psychoneurological deficits of progeny. Ann Clin Lab Sci 1991;21:227–39.PubMedGoogle Scholar
  36. 36.
    Lockshin MD, Druzin ML, Goei S, et al. Antibody to car-diolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985;313:152–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Lubbe WF, Butler WS, Palmer SJ, Liggins GC. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet 1983;1:1361–3.PubMedCrossRefGoogle Scholar
  38. 38.
    Antenatal diagnosis of genetic disorders. Technical Bulletin No. 108. Washington, DC: American College of Obstetricians and Gynecologists, 1987.Google Scholar
  39. 39.
    Lemna WK, Feldman GL, Kerem B-S, et al. Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med 1990;322:291–6.PubMedCrossRefGoogle Scholar
  40. 40.
    MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131–7.CrossRefGoogle Scholar
  41. 41.
    Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832–5.PubMedCrossRefGoogle Scholar
  42. 42.
    Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992;41:1–8.Google Scholar
  43. 43.
    Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257–61.PubMedCrossRefGoogle Scholar
  44. 44.
    Daly LE, Peadar NK, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects: implications for prevention. JAMA 1995;274:1698–702.PubMedCrossRefGoogle Scholar
  45. 45.
    Naeye RL. Weight gain and the outcomes of pregnancy. Am J Obstet Gynecol 1979;135:3–9.PubMedGoogle Scholar
  46. 46.
    Johnson SR, Kolberg BH, Varner MWS, Railsback LD. Maternal obesity and pregnancy. Surg Gynecol Obstet 1987;164: 431–7.PubMedGoogle Scholar
  47. 47.
    Bucher HC, Guyatt G, Cook RJ, et al. Effect of calcium supplementation on pregnancy induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA 1996;275:1113–7.PubMedCrossRefGoogle Scholar
  48. 48.
    McCarron DA, Hatton D. Dietary calcium and lower blood pressure: we can all benefit [editorial]. JAMA 1996;275: 1128–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Rothman KJ, Moore LL, Singer MR, et al. Teratogenicity of high vitamin A intake. N Engl J Med 1995;333:1369–73.PubMedCrossRefGoogle Scholar
  50. 50.
    Drogari E, Smith I, Beasley M, Lloyd JK. Timing of strict diet in relation to fetal damage in maternal phenylketonuria. Lancet 1987;2:927–30.PubMedCrossRefGoogle Scholar
  51. 51.
    Platt LD, Koch R, Azen C, et al. Maternal phenylketonuria collaborative study, obstetric aspects and outcome: the first 6 years. Am J Obstet Gynecol 1992;166:1150–62.PubMedCrossRefGoogle Scholar
  52. 52.
    Gazamarian JA, Lazoricks S, Spitz AM, et al. Prevalence of violence against pregnant women. JAMA 1996;275:1915–20.CrossRefGoogle Scholar
  53. 53.
    Thompson JE. Maternal stress, anxiety, and social support during pregnancy: possible direction for prenatal intervention. In: Merkatz IR, Thompson JE, Mullen PD, Goldenberg R, editors. New perspectives on prenatal care. New York: Elsevier, 1990:319–35.Google Scholar
  54. 54.
    DiFranza JR, Lew RA. Effect of maternal cigarette smoking on pregnancy complications and sudden infant death syndrome. J Fam Pract 1995;40:385–94.PubMedGoogle Scholar
  55. 55.
    Williamson DF, Serdula MK, Kendrick JS, Binkin MJ. Comparing the prevalence of smoking in pregnant and nonpregnant women, 1985 to 1986. JAMA 1989;261:70–4.PubMedCrossRefGoogle Scholar
  56. 56.
    Fox SH, Brown C, Koontz AM, Kessel SS. Perceptions of risks of smoking and heavy drinking during pregnancy: 1985 NHIS findings. Public Health Rep 1987;102:73–9.Google Scholar
  57. 57.
    Waren KR, Bast RJ. Alcohol-related birth defects: an update. Public Health Rep 1988;103:638–42.Google Scholar
  58. 58.
    Hanson JW, Streissguth AP, Smith DW. The effects of moderate alcohol consumption during pregnancy on fetal growth and morphogenesis. J Pediatr 1978;92:457–60.PubMedCrossRefGoogle Scholar
  59. 59.
    Hadeed AJ, Siegel SR. Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics 1989;84: 205–10.PubMedGoogle Scholar
  60. 60.
    MacGregor SN, Keith LG, Chasnoff IJ, et al. Cocaine use during pregnancy: adverse perinatal outcome. Am J Obstet Gynecol 1987;157:686–90.PubMedGoogle Scholar
  61. 61.
    National Association for Perinatal Addiction Research and Education. Innocent addicts: high rate of prenatal drug abuse found. ADAMHA News. Rockville, MD: National Institute on Drug Abuse, October 1988.Google Scholar
  62. 62.
    Chasnoff IJ. Cocaine: effects on pregnancy and the neonate. In: Drugs, alcohol, pregnancy and parenting. Dordrecht: Kluwer, 1988:97–103.CrossRefGoogle Scholar
  63. 63.
    Whitley RJ, Goldenberg RL. Infectious disease in the prenatal period and recommendations for screening. In: Merkatz IR, Thompason JE, Mullen PD, Goldenberg RL, editors. New perspective on prenatal care. New York: Elsevier, 1990:363–406.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Brian W. Jack
  • Larry Culpepper

There are no affiliations available

Personalised recommendations